These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. [Treatment of invasive fungal infections with voriconazole. Evaluation of experience with compassionate use of voriconazole in Spain]. Díaz Pedroche C, Cisneros JM, Lumbreras C, Aguado JM, Grupo Clinico Espanol de Estudio de Voriconazol. Rev Esp Quimioter; 2005 Jun; 18(2):149-58. PubMed ID: 16130037 [Abstract] [Full Text] [Related]
24. Treating disseminated fusariosis: amphotericin B, voriconazole or both? Ho DY, Lee JD, Rosso F, Montoya JG. Mycoses; 2007 May; 50(3):227-31. PubMed ID: 17472622 [Abstract] [Full Text] [Related]
25. An open-label comparative pilot study of oral voriconazole and itraconazole for long-term treatment of paracoccidioidomycosis. Queiroz-Telles F, Goldani LZ, Schlamm HT, Goodrich JM, Espinel-Ingroff A, Shikanai-Yasuda MA. Clin Infect Dis; 2007 Dec 01; 45(11):1462-9. PubMed ID: 17990229 [Abstract] [Full Text] [Related]
31. Forum report: issues in clinical trials of empirical antifungal therapy in treating febrile neutropenic patients. Bennett JE, Powers J, Walsh T, Viscoli C, de Pauw B, Dismukes W, Galgiani J, Glauser M, Herbrecht R, Kauffman C, Lee J, Pappas P, Rex J, Verweij P. Clin Infect Dis; 2003 Apr 15; 36(Suppl 3):S117-22. PubMed ID: 12679895 [Abstract] [Full Text] [Related]
32. Comparative pharmacokinetics of voriconazole administered orally as either crushed or whole tablets. Dodds Ashley ES, Zaas AK, Fang AF, Damle B, Perfect JR. Antimicrob Agents Chemother; 2007 Mar 15; 51(3):877-80. PubMed ID: 17145785 [Abstract] [Full Text] [Related]
33. Immediate versus deferred empirical antifungal (IDEA) therapy in high-risk patients with febrile neutropenia: a randomized, double-blind, placebo-controlled, multicenter study. Maschmeyer G, Heinz WJ, Hertenstein B, Horst HA, Requadt C, Wagner T, Cornely OA, Löffler J, Ruhnke M, IDEA study investigators. Eur J Clin Microbiol Infect Dis; 2013 May 15; 32(5):679-89. PubMed ID: 23271674 [Abstract] [Full Text] [Related]
34. Voriconazole-induced blistering in the setting of graft versus host disease: A report of 2 patients. Conlon JD, Dauenhauer M, Tonkovic-Capin V, Talano J, Margolis D, Drolet BA, Fairley JA. J Am Acad Dermatol; 2008 Mar 15; 58(3):484-7. PubMed ID: 18280346 [Abstract] [Full Text] [Related]
35. Voriconazole therapy in children with cystic fibrosis. Hilliard T, Edwards S, Buchdahl R, Francis J, Rosenthal M, Balfour-Lynn I, Bush A, Davies J. J Cyst Fibros; 2005 Dec 15; 4(4):215-20. PubMed ID: 16243008 [Abstract] [Full Text] [Related]